Seattle Genetics
About Seattle Genetics
Seattle Genetics is a biotechnology company focused on developing monoclonal antibody (mAb)-based therapeutics for cancer and immunologic diseases.
PIPELINE
SGN-30 is a genetically engineered antibody targeting the CD30 antigen, which is expressed on many types of hematologic malignancies such as Hodgkin's disease and some types of non-Hodgkin's lymphoma.
SGN-15 is an antibody-drug conjugate (ADC) composed of a genetically engineered antibody targeted to an antigen that is conjugated to doxorubicin.A phase II clinical trial has been completed using SGN-15 for the treatment of non-small cell lung cancer in combination with Taxotere.
SGN-40 is a humanized antibody targeted to the CD40 antigen -- target sites are hematologic malignancies such as multiple myeloma and non-Hodgkin's lymphoma.
Key Statistics for Seattle Genetics
Basic Chart for Seattle Genetics